Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

EASL Clinical Practice Guidelines: Management of alcohol-related liver disease
Mark Thursz, Antoni Gual, C. Lackner, et al.
Journal of Hepatology (2018) Vol. 69, Iss. 1, pp. 154-181
Open Access | Times Cited: 757

Showing 1-25 of 757 citing articles:

EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update
Annalisa Berzigotti, Emmanuel Tsochatzis, Jérôme Boursier, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 3, pp. 659-689
Open Access | Times Cited: 1135
Alcoholic liver disease
Helmut K. Seitz, Ramón Bataller, Helena Cortez‐Pinto, et al.
Nature Reviews Disease Primers (2018) Vol. 4, Iss. 1
Closed Access | Times Cited: 886
Epidemiology of non-alcoholic and alcoholic fatty liver diseases
Souveek Mitra, Arka De, Abhijit Chowdhury
Translational Gastroenterology and Hepatology (2020) Vol. 5, pp. 16-16
Open Access | Times Cited: 412
Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
Anton Gillessen, Hartmut Schmidt
Advances in Therapy (2020) Vol. 37, Iss. 4, pp. 1279-1301
Open Access | Times Cited: 354
Hepatocellular carcinoma in the setting of alcohol-related liver disease
Nathalie Ganne‐Carrié, Pierre Nahon
Journal of Hepatology (2019) Vol. 70, Iss. 2, pp. 284-293
Open Access | Times Cited: 284
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
Frank Tacke, Paul Horn, Vincent Wai‐Sun Wong, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 3, pp. 492-542
Closed Access | Times Cited: 281
Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors
Daniel Q. Huang, Philippe Mathurin, Helena Cortez‐Pinto, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 1, pp. 37-49
Open Access | Times Cited: 272
Targeted and Immune-Based Therapies for Hepatocellular Carcinoma
Tim F. Greten, Chunwei W. Lai, Guangfu Li, et al.
Gastroenterology (2018) Vol. 156, Iss. 2, pp. 510-524
Open Access | Times Cited: 249
Fibrosis and alcohol-related liver disease
Carolin Lackner, Dina Tiniakos
Journal of Hepatology (2019) Vol. 70, Iss. 2, pp. 294-304
Open Access | Times Cited: 232
MAFLD: How is it different from NAFLD?
Cameron Gofton, Yadhavan Upendran, Ming‐Hua Zheng, et al.
Clinical and Molecular Hepatology (2022) Vol. 29, Iss. Suppl, pp. S17-S31
Open Access | Times Cited: 232
Coronavirus Disease 2019 Hangover: A Rising Tide of Alcohol Use Disorder and Alcohol‐Associated Liver Disease
Ben L. Da, Gene Y. Im, Thomas D. Schiano
Hepatology (2020) Vol. 72, Iss. 3, pp. 1102-1108
Closed Access | Times Cited: 227
PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis
Jonel Trebicka, Javier Fernández, Mária Papp, et al.
Journal of Hepatology (2020) Vol. 74, Iss. 5, pp. 1097-1108
Open Access | Times Cited: 213
Non-alcoholic fatty liver disease: A patient guideline
Sven Francque, Giulio Marchesini, Achim Kautz, et al.
JHEP Reports (2021) Vol. 3, Iss. 5, pp. 100322-100322
Open Access | Times Cited: 205
The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality
Tom H. Karlsen, Nick Sheron, Shira Zelber‐Sagi, et al.
The Lancet (2021) Vol. 399, Iss. 10319, pp. 61-116
Open Access | Times Cited: 170
Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting
Matías A. Ávila, Jean‐François Dufour, Alexander L. Gerbes, et al.
Gut (2019) Vol. 69, Iss. 4, pp. 764-780
Open Access | Times Cited: 158
Non-invasive diagnosis and biomarkers in alcohol-related liver disease
Christophe Moreno, Sebastian Mueller, Gyöngyi Szabó
Journal of Hepatology (2019) Vol. 70, Iss. 2, pp. 273-283
Open Access | Times Cited: 152
Global Burden of Alcohol Use Disorders and Alcohol Liver Disease
Jürgen Rehm, Kevin D. Shield
Biomedicines (2019) Vol. 7, Iss. 4, pp. 99-99
Open Access | Times Cited: 152
Alcoholic Hepatitis: A Review
Nooshin Hosseini, Julia Shor, Gyöngyi Szabó
Alcohol and Alcoholism (2019) Vol. 54, Iss. 4, pp. 408-416
Open Access | Times Cited: 146
Microbiome-derived ethanol in nonalcoholic fatty liver disease
Abraham S. Meijnikman, Mark Davids, Hilde Herrema, et al.
Nature Medicine (2022) Vol. 28, Iss. 10, pp. 2100-2106
Closed Access | Times Cited: 129
Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease
Katharina Staufer, Ursula Huber-Schönauer, Georg Strebinger, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 918-930
Open Access | Times Cited: 127
EASL Clinical Practice Guidelines on haemochromatosis
Heinz Zoller, Benedikt Schaefer, Annick Vanclooster, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 2, pp. 479-502
Open Access | Times Cited: 110
Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives
Szu-Yi Liu, I‐Ting Tsai, Yin-Chou Hsu
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5170-5170
Open Access | Times Cited: 102
The stigma of alcohol-related liver disease and its impact on healthcare
Georg Schomerus, Anya Leonhard, Jakob Manthey, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 2, pp. 516-524
Open Access | Times Cited: 101
The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease
Luis Antonio Díaz, Juan Pablo Arab, Alexandre Louvet, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 12, pp. 764-783
Closed Access | Times Cited: 92
Role of silymarin as antioxidant in clinical management of chronic liver diseases: a narrative review
Alessio Aghemo, О. П. Алексеева, Francesco Angelico, et al.
Annals of Medicine (2022) Vol. 54, Iss. 1, pp. 1548-1560
Open Access | Times Cited: 69
Page 1 - Next Page

Scroll to top